A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
Closed to Enrollment
The purpose of this study is to evaluate how tolerable, safe, and effective it is to give INO-8875 eye drops to adults with glaucoma or ocular hypertension.
Ages Eligible for Study: 18 Years to 75 Years
Genders Eligible for Study: Both
- Subjects with the diagnosis of ocular hypertension (OHT) or primary open-angle glaucoma (POAG).
- Aged 18 to 75 years.
- Mean intraocular pressure (IOP) of â‰¥24 and â‰¤34 mm Hg.